Posted in | News

Skanska Makes Investment in Office Building in Oslo, Norway

Skanska Commercial Development Norway invests about NOK 530 M, about SEK 570 M, in office building in Oslo, Norway, in a 50/50 joint venture with Entra named Sundtkvartalet AS.

The construction contract is worth about NOK 680 M, about SEK 740 M, and will be included in order bookings for Skanska Norway in the second quarter of 2014.

The office building will have a leasable area of about 30,000 square meters, and have a strong focus on energy efficiency. Skanska Norway AS has signed a lease contract with Sundtkvartalet AS, and will move into the new office building, as one of several tenants, when it is completed.

Construction will start in October 2014, with completion scheduled for early 2017.

Skanska Commercial Development Nordic initiates and develops property projects in offices, logistics, business premises and commercial buildings. The company’s operations are concentrated in the three metropolitan regions in Sweden, the Copenhagen region in Denmark, the Oslo region in Norway, as well as Helsinki in Finland. The development of logistics and volume retail properties is conducted in strategic locations in Sweden, Denmark and Finland.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Skanska. (2019, February 21). Skanska Makes Investment in Office Building in Oslo, Norway. AZoBuild. Retrieved on November 23, 2024 from https://www.azobuild.com/news.aspx?newsID=18589.

  • MLA

    Skanska. "Skanska Makes Investment in Office Building in Oslo, Norway". AZoBuild. 23 November 2024. <https://www.azobuild.com/news.aspx?newsID=18589>.

  • Chicago

    Skanska. "Skanska Makes Investment in Office Building in Oslo, Norway". AZoBuild. https://www.azobuild.com/news.aspx?newsID=18589. (accessed November 23, 2024).

  • Harvard

    Skanska. 2019. Skanska Makes Investment in Office Building in Oslo, Norway. AZoBuild, viewed 23 November 2024, https://www.azobuild.com/news.aspx?newsID=18589.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.